Interventional Cardiology Market - Trends Forecast Till 2028

Interventional Cardiology Market, By Type (Balloons, Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others), System (Fractional Flow Reserve (FFR) System, Intravascular Ultrasound (IVUS) Systems, Optical Coherence Tomography (OCT) Systems), End Users (Hospitals, Surgical Centers, Cardiac Centers, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-ICM-38

Format:  

Number of Pages: 325

Domain: Healthcare

Interventional Cardiology Market – Trends Forecast Till 2028

The global interventional cardiology market is anticipated to reach USD 25.93 billion by 2020 growing at a CAGR of 7.9% during the forecasting period, 2020-2028. Interventional cardiology is the cardiology which deals with the catheter-based treatment of structural heart diseases. It helps in the avoidance of scars and pain, and long post-operative recovery. Factors such as the rising geriatric population due to higher life expectancy and increasing clinical evidence of the effectiveness of advanced interventional cardiac devices are some of the major drivers for the interventional cardiology market

Interventional Cardiology Market – Trends Forecast Till 2028

The global interventional cardiology market is segmented into type, system, end-user, and geography.

The type segment is segmented into Balloons, Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others

System segment is segmented into Fractional Flow Reserve (FFR) System, Intravascular Ultrasound (IVUS) Systems and Optical Coherence Tomography (OCT) Systems

End Users segment is segmented into Hospitals, Surgical Centers, Cardiac Centers, and Others

Geographically, the global interventional cardiology market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions. 

North America region is the largest contributor to the interventional cardiology market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Key players in the global interventional cardiology market are Abiomed, Inc., ACIST Medical Systems, Inc., B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Life Vascular Devices Biotech S.L., Biostense Webster, Inc., Medtronic Plc, Merit Medical Systems, Inc., Novacam Technologies Inc., Koninklijke Philips N.V., St. Jude Medical, Terumo Corporation, and W.L. Gore & Associates, Inc among others

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2018, Boston Scientific Corporation has announced to acquire Claret Medical, Inc. which has developed and commercialized the Sentinel Cerebral Embolic Protection System which is used for protecting the brain during certain interventional procedures.
  • In 2019, Abiomed has announced the launch of Impella CP with SmartAssist, which is designed for improving patient outcomes with advanced algorithms and simplified patient management at the 2019 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions.

Hence, tremendous progress has been made over the last decade and yet a lot more to come in the recent years

Available Customizations

In addition to the market data for the interventional cardiology market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, a conference like Jefferies conference)—to identify and collect information useful for this study of the interventional cardiology market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global interventional cardiology market. Through secondary, the market is classified and segmented as per industry trends, developments, regional markets, products, and technological developments. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the interventional cardiology market.

The primary respondent breakdown is provided below:

Interventional Cardiology Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the interventional cardiology market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact the primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the interventional cardiology market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 25.93 billion

Growth Rate

CAGR of 7.9% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year 

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Type, System, End-User, and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Abiomed, Inc., ACIST Medical Systems, Inc., B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Life Vascular Devices Biotech S.L., Biostense Webster, Inc., Medtronic Plc, Merit Medical Systems, Inc., Novacam Technologies Inc., Koninklijke Philips N.V., St. Jude Medical, Terumo Corporation, and W.L. Gore & Associates, Inc among others

Available Customization 

In addition to the market data for the interventional cardiology market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

 

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.